Search

The use of spirulina and its efficiency have been studied in a comparative aspect as a systemic biocorrector, in a combined treatment of tuberculosis in 26 children. It has been ascertained that application of spirulina as a pathogenetic means of remediation permits shortening the intoxication syndrome regression time, reducing the frequency of adverse reactions in administering antituberculous preparations.

A study was made into effects of food supplements EKSO, Biotrit C, SPLAT and their combinations on the level of health in young persons (students, n = 75) using the G. L. Apanasenko's method and its modification. the administration of Biotrit C (a drug obtained from wheat germs), EKSO (containing soy isoflavones) and their combinations have been found to raise the level of health in those subjects enrolled in the study. The results secured permit recommending Biotrit C and EKSO as adaptogens.

The results of examination of 60 patients presenting with chronic diffuse disorders of the liver and seventy experimental animals with toxic affection of the liver, having been administered spirulina treatments, suggest clinical-and-laboratory effectiveness of this drug. The hepatoprotective properties of spirulina are referrable to its antiinflammatory, antioxidant, membrane-stabilizing, and immunocorrecting actions. In this way the employment of spirulina is believed to be pathogenetically validated in chronic diffuse liver conditions, permitting stabilizing the process and preventing the transformation of chronic hepatitis into hepatocirrhosis.

New high-protein vitamin product "Biostim" and bisquaternary ammonium compound etonium have been studied for their effect on the content of endogenic lipids (isolated binary bonds, diene conjugates, ketodienes and conjugated trienes) and reduced glutathione in the stomach and liver tissues under experimental duodenal ulcer with results presented. Maximal effect of "Biostim" on the intensity of the processes of free-radical oxidation in these tissue falls on the 14th day of the experiment, that of etonium on the 10th day, their simultaneous use--on the 6th day of the treatment. It is supposed that the combination of the above drugs takes most pronounced antioxidant effect owing to the fact that etonium activates the operation of glutathione cycle, promotes blocking of formation of free radicals and interacts with them. Under these conditions biosynthetic processes in the cell membranes induced by "Biostim" are more intensive and this, in its turn, promotes free-radical inhibition of lipids and biopolymers.